Effects of Intranasal Oxytocin on Striatal Functional Connectivity
NCT ID: NCT03128203
Last Updated: 2017-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
135 participants
INTERVENTIONAL
2016-09-30
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Neural Basis of Oxytocin's Effects on Empathy
NCT03084029
Oxytocin's Effect on the Advantageous- and Disadvantageous-inequity
NCT06405737
Effects of Oxytocin on Reinforcement Learning and Interoception
NCT05245708
The Effects of Oxytocin and Vasopressin on Delta-beta Cross-frequency Coupling
NCT06605300
The Modulatory Effect of Oxytocin on Interoception
NCT03074409
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subject will receive either intranasal oxytocin or placebo administration and go through a seven-minute resting-state scan in MRI scanner to test whether oxytocin changes functional connectivity in the brain. Trait anxiety and mood questionnaires will be administered as control variables.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oxytocin
Oxytocin
Oxytocin, intranasally administrated
Placebo
Placebos
Saline, intranasally administrated
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxytocin
Oxytocin, intranasally administrated
Placebos
Saline, intranasally administrated
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Electronic Science and Technology of China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Benjamin Becker
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin Becker, Dr.
Role: PRINCIPAL_INVESTIGATOR
School of Life Science and Technology, University of Electronic Science and Technology of China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Life Science and Technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UESTC-neuSCAN-36
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.